# TIL-Driven De-escalated Chemotherapy in Stage I-II TNBC

> **NCT07074106** · PHASE2 · RECRUITING · sponsor: **D'Or Institute for Research and Education** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Carboplatin and a Taxane

## Key facts

- **NCT ID:** NCT07074106
- **Lead sponsor:** D'Or Institute for Research and Education
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-31
- **Primary completion:** 2027-07-01
- **Final completion:** 2028-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07074106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07074106, "TIL-Driven De-escalated Chemotherapy in Stage I-II TNBC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07074106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*